SCHEDULE 13G/A: ARK Investment Management Discloses 4.49% Stake in CareDx, Inc.

ARK Investment Management LLC has filed an amended Schedule 13G, reporting a 4.49% beneficial ownership stake in CareDx, Inc. as of December 31, 2024.

Summary

• ARK Investment Management LLC, an investment adviser, has filed an Amendment No. 6 to Schedule 13G regarding its beneficial ownership in CareDx, Inc.
• As of December 31, 2024, ARK Investment Management LLC beneficially owns 2,409,099 shares of CareDx, Inc. Common Stock.
• This ownership represents 4.49% of the total class of securities outstanding.
• ARK Investment Management LLC holds sole voting power and sole dispositive power over all 2,409,099 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of CareDx, Inc.

Sentiment

Score: 5

Explanation: The document is a standard Schedule 13G filing, which is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The disclosure of a significant stake by ARK Investment Management LLC, a prominent investment adviser, may signal institutional confidence or interest in CareDx, Inc.

Negatives

• The reported stake of 4.49% is below the 5% threshold, meaning ARK Investment Management LLC is not a 5% beneficial owner of CareDx, Inc. common stock, which would trigger different reporting requirements.

Risks

• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Any change in this stated intent would necessitate a different filing (Schedule 13D), which could indicate a more activist stance.

Future Outlook

NA

Management Comments

• Kellen Carter, Chief Compliance Officer of ARK Investment Management LLC, certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of CareDx, Inc.

Industry Context

This filing is a standard regulatory disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive dynamics within the healthcare or diagnostics sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership in CareDx, Inc.

Next Steps

• Continued compliance with SEC reporting requirements for beneficial ownership by ARK Investment Management LLC.

Key Dates

Keywords

CareDx, ARK Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Investor